Study Assessing Immunogenicity and Safety of IC43 In Intensive Care Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00876252
Recruitment Status : Completed
First Posted : April 6, 2009
Last Update Posted : October 19, 2012
Information provided by (Responsible Party):
Valneva Austria GmbH